☆ 4.1 Article

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines

THERAPIE (2023)

Related references

Note: Only part of the references are listed.

Article Obstetrics & Gynecology

Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France

Noemie Roland et al.

Summary: The COVID-19 pandemic has had a significant impact on the use of reimbursed contraceptives in France, particularly for long-acting contraceptives and women under the age of 25. Ensuring access to contraceptive methods during health emergencies should be a priority in public health policy.

CONTRACEPTION (2022)

Add to Collection

Letter Medicine, General & Internal

Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older

Marie Joelle Jabagi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Mathematical & Computational Biology

A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety

Yonas Ghebremichael-Weldeselassie et al.

Summary: This paper proposes a modified self-controlled case series (SCCS) method to study the safety of COVID-19 vaccines. By using case studies and simulations, the authors investigate the biases that may arise from event-dependence and high event-related mortality, and present a new testing method.

STATISTICS IN MEDICINE (2022)

Add to Collection

Article Immunology

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines

Jeremie Botton et al.

Summary: Randomized clinical trials have shown mRNA-based vaccines to be 92-95% effective to prevent COVID-19 in adults. This study aimed to estimate the impact of vaccination on the risk of severe COVID-19 in elderly people and found that vaccination reduces the risk of hospitalization by approximately 86% in individuals aged 75 and older.

VACCINE (2022)

Add to Collection

Letter Medicine, General & Internal

Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations

Jeremie Botton et al.

JAMA NETWORK OPEN (2022)

Add to Collection

Article Medicine, General & Internal

Routine surgeries during the COVID-19 pandemic: A French nationwide cohort study

Emmanuelle Dufour et al.

Summary: Analysis of data showed that during the COVID-19 pandemic, the activity levels of four routine surgical procedures were significantly lower than expected, with no significant improvement in the first half of 2021.

ANNALS OF MEDICINE AND SURGERY (2022)

Add to Collection

Article Multidisciplinary Sciences

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

Stephane Le Vu et al.

Summary: Cases of myocarditis and pericarditis have been reported following COVID-19 mRNA vaccination, with increased risks during the first week after vaccination, particularly after the second dose. The mRNA-1273 vaccine shows the largest association with myocarditis, especially in individuals aged 18 to 24 years. The burden of both myocarditis and pericarditis attributable to vaccination is significant across different age groups and in both males and females.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Medicine, General & Internal

Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France

Jeremie Botton et al.

Summary: This study assessed the short-term risk for severe cardiovascular events after COVID-19 vaccination in adults younger than 75 years in France. The study found that adenoviral-based vaccines may be associated with an increased incidence of myocardial infarction and pulmonary embolism, while mRNA-based vaccines showed no association with the cardiovascular events studied.

ANNALS OF INTERNAL MEDICINE (2022)

Add to Collection

Article Health Care Sciences & Services

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France

Laura Semenzato et al.

Summary: Based on data from the national COVID-19 vaccination database and the National Health Data System in France, older age, male gender, social deprivation, comorbidities, and immunosuppressive therapy were found to be associated with an increased risk of COVID-19-related hospitalization or in-hospital death in fully vaccinated individuals.

LANCET REGIONAL HEALTH-EUROPE (2022)

Add to Collection

Article Hematology

No association of low-dose aspirin with severe COVID-19 in France: A cohort of 31.1 million people without cardiovascular disease

Jeremie Botton et al.

Summary: This study investigated the association between the use of low-dose aspirin for primary cardiovascular prevention and the risk of severe COVID-19. The results showed a positive association between low-dose aspirin and hospitalization and death/intubation risk. However, after full adjustment, the association became close to null.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Peripheral Vascular Disease

Antihypertensive Drugs and COVID-19 Risk A Cohort Study of 2 Million Hypertensive Patients

Laura Semenzato et al.

Summary: Recent evidence suggests that hypertensive patients treated with ACE inhibitors or ARBs may have a lower risk of COVID-19 hospitalization and intubation/death compared to those treated with CCBs. This contradicts initial hypotheses regarding the association between renin-angiotensin-aldosterone system inhibitors and COVID-19 risk, raising new questions for further research.

HYPERTENSION (2021)

Add to Collection

Article Gastroenterology & Hepatology

Colonoscopy in France during the COVID-19 pandemic

Antoine Meyer et al.

Summary: During the COVID-19 pandemic in France, dispensing of colonoscopy preparations significantly decreased during the national lockdown and gradually returned to expected levels after the lockdown. An estimated decrease of roughly 250,000 colonoscopy preparations during the first six months of the pandemic was observed, with similar patterns across different age groups, gender, and levels of deprivation index.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2021)

Add to Collection

Letter Ophthalmology

Intravitreal Anti-Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic

Sophie Billioti de Gage et al.

Summary: This cohort study utilizes data from the French National Health Data System to assess the decline in intravitreal anti-vascular endothelial growth factors usage before, during, and after pandemic lockdown periods.

JAMA OPHTHALMOLOGY (2021)

Add to Collection

Article Obstetrics & Gynecology

Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France

Noemie Roland et al.

OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Letter Dermatology

Drop in biological initiation for patients with psoriasis during the COVID-19 pandemic

L. Penso et al.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Article Pediatrics

Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020

Marion Taine et al.

Summary: During the first lockdown in France, there were significant decreases in the dispensation of both priming doses and boosters for infants, particularly for MMR priming doses and Men-C-C boosters. Although vaccination counts slightly increased after the lockdown, they remained below the expected numbers.

FRONTIERS IN PEDIATRICS (2021)

Add to Collection

Article Health Care Sciences & Services

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people

Laura Semenzato et al.

Summary: In France, the risk of COVID-19 hospitalization and mortality is associated with age, gender, social deprivation, and various chronic health conditions. Down syndrome, mental retardation, kidney transplantation, lung transplantation, end-stage renal disease, and active lung cancer show the strongest associations with COVID-19 risk.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

© Peeref 2019-2024. All rights reserved.